
A drug candidate called YCT-529, which creator YourChoice Therapeutics is angling to make the first non-hormonal contraceptive pill for men, entered its Phase 1 clinical trial on December 13 in the U.K. This round will test the pill’s safety, tolerability, and oral dosage function in 16 participants.